Vimarsana
Biggest News Aggregation in the World

Page 4 - Current Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Management Today - Breaking & Trending Today

Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress - Vimarsana News

Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress

Published: January 22, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from a...

Source: prnewswire.com
Related Topics:
United StatesSan FranciscoRyan TaylorHeather GuzziPrashant PandyaKhurram JamilPrnewswire MallinckrodtDanielj SpecialeDerek BelzRam SubramanianMallinckrodt PharmaceuticalsClinical Development Critical CareNational Organization For Rare DisordersCritical Care Congress OnUnited States Census BureauExchange CommissionMallinckrodt Hospital Products IncAmerican College Of GastroenterologySociety Of Critical Care MedicineMoscone CenterGreen Room CommunicationsCritical Care Congress MeetingCritical Care CongressNorth American CentricScare Congress
Alleviating the Aggravation of Dry Eyes - Vimarsana News

Alleviating the Aggravation of Dry Eyes

Published: November 20, 2022

This article is part two of a two-part series. Part one ran last week and described the symptoms, ...

Source: theepochtimes.com
Related Topics:
United StatesUnited KingdomAmerican Academy Of OptometryVanderbilt UniversityBritish Contact Lens AssociationDry Eye Disease OutsideEnvironmental FactorsLid HygieneFlow Thermal Pulsation SystemBritish JournalVitamind SupplementationDry Eye Syndrome RefractoryPragmatic ApproachDry Eye DiagnosisAmerican AcademyInvestigative OphthalmologyRetrieved OctoberVarenicline Solution Nasal SprayDry EyeAcid SupplementationDry Eye DiseaseRandomized ClinicalCurrent ManagementMeibomian Gland DysfunctionDry Eyes
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific Meeting

Published: November 1, 2022

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that three scientific abstracts on clinical...

Source: prnewswire.com
Related Topics:
United StatesOrange County Convention CenterNew OrleansMuhammad Ahmad MujtabaRyan TaylorHeather GuzziShehzad NawazPrashant PandyaKhurram JamilPrnewswire MallinckrodtDanielj SpecialeDerek BelzJuan Carlosq VelezMallinckrodt PharmaceuticalsClinical Development Critical CareNational Organization For Rare DisordersRenal Drugs Advisory CommitteeUnited States Census BureauExchange CommissionMallinckrodt Hospital Products IncOchsner Health NetworkAmerican Society Of NephrologyGreen Room CommunicationsAmerican Society Of Nephrology Kidney WeekMallinckrodt Pharmaceuticals Terlipressin Advisory Committee Briefing Document
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

Published: October 24, 2022

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that five scientific abstracts on the clinical...

Source: prnewswire.com
Related Topics:
United StatesNorth CarolinaRyan TaylorK Rajender ReddyR Todd FrederickXingyue HuangHeather GuzziRobert WongPrashant PandyaKhurram JamilPrnewswire MallinckrodtDanielj SpecialeNikolaos PyrsopoulosDerek BelzMallinckrodt PharmaceuticalsClinical Development Critical CareNational Organization For Rare DisordersRenal Drugs Advisory CommitteeCalifornia Pacific Medical CenterUnited States Census BureauExchange CommissionAmerican College Of GastroenterologyGreen Room CommunicationsMallinckrodt Pharmaceuticals Terlipressin Advisory Committee Briefing DocumentAmerican College
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) - Vimarsana News

Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)

Published: September 15, 2022

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...

Source: prnewswire.com
Related Topics:
United StatesSteven RomanoRyan TaylorHeather GuzziPrashant PandyaJoele FrankMichael Freitag Aaron PalashSiggi OlafssonPrnewswire MallinckrodtDanielj SpecialeDerek BelzWilkinson Brimmer KatcherMallinckrodt PharmaceuticalsNational Organization For Rare DisordersRenal Drugs Advisory CommitteeDrug AdministrationUnited States Census BureauExchange CommissionAmerican College Of GastroenterologyGreen Room CommunicationsMallinckrodt Pharmaceuticals Terlipressin Advisory Committee Briefing DocumentImportant Safety InformationBoxed WarningChief Executive OfficerAmerican Association